127 related articles for article (PubMed ID: 23992231)
1. Concentrated sodium chloride catheter lock solution--a new effective alternative method for hemodialysis patients with high bleeding risk.
Chen FK; Li JJ; Song Y; Zhang YY; Chen P; Zhao CZ; Gong HY; Yao DF
Ren Fail; 2014 Feb; 36(1):17-22. PubMed ID: 23992231
[TBL] [Abstract][Full Text] [Related]
2. Low-dose heparin retention in temporary hemodialysis double-lumen catheter does not increase catheter occlusion and might reduce risk of bleeding.
Hu HH; Hsu CY; Fang HC; Lee PT; Chen CL; Chang TY; Huang WC; Chung HM; Chou KJ
Blood Purif; 2011; 32(3):232-7. PubMed ID: 21829015
[TBL] [Abstract][Full Text] [Related]
3. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
Saxena AK; Panhotra BR
J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
[TBL] [Abstract][Full Text] [Related]
4. Clinical consequences of heparin-free hemodialysis.
McGill RL; Blas A; Bialkin S; Sandroni SE; Marcus RJ
Hemodial Int; 2005 Oct; 9(4):393-8. PubMed ID: 16219060
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
6. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
[TBL] [Abstract][Full Text] [Related]
7. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial.
Deng Y; Xing J; Tan Z; Ai X; Li Y; Zhang L
PLoS One; 2023; 18(7):e0288117. PubMed ID: 37399185
[TBL] [Abstract][Full Text] [Related]
9. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
[TBL] [Abstract][Full Text] [Related]
10. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
Maki DG; Ash SR; Winger RK; Lavin P;
Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
[TBL] [Abstract][Full Text] [Related]
11. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
[TBL] [Abstract][Full Text] [Related]
12. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
Thomson PC; Morris ST; Mactier RA
Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
[TBL] [Abstract][Full Text] [Related]
13. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety and efficacy of argatroban locking solution in the prevention of the dysfunction of haemodialysis central venous catheters: a study protocol for a randomized controlled trial.
Wang Y; Liu C; Zhang L; Li J; Zhang L; Wang Y; Zhu H; Cao X; Wu D; Wu J; Lin S; Feng Z; Cai G; Chen X; Sun X
Ann Palliat Med; 2021 Feb; 10(2):2260-2270. PubMed ID: 33549029
[TBL] [Abstract][Full Text] [Related]
15. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
[TBL] [Abstract][Full Text] [Related]
16. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis.
Kaneko Y; Iwano M; Yoshida H; Kosuge M; Ito S; Narita I; Gejyo F; Suzuki M
Blood Purif; 2004; 22(5):473-9. PubMed ID: 15523172
[TBL] [Abstract][Full Text] [Related]
17. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
18. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
Grudzinski L; Quinan P; Kwok S; Pierratos A
Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems].
Pelayo Alonso R; Cobo Sánchez JL; de Buruaga Perea AS; Menezo Viadero R; Gándara Revuelta M; Aja Crespo A; Tovar Rincón A
Rev Enferm; 2013 Mar; 36(3):8-12. PubMed ID: 23654184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]